CorePharma Overview

  • Founded
  • 1998

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Debt - PPP

  • Financing Rounds
  • 6

  • Investments
  • 1

CorePharma General Information

Description

Developer and manufacturer of solid dose generic pharmaceuticals, including prescription and over-the-counter products. The company's focuses on solid oral dosage forms, both modified and immediate release dosage forms and controlled drug products under various brands, enabling patients to get over chronic diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 215 Wood Avenue
  • Middlesex, NJ 08846
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CorePharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CorePharma‘s full profile, request access.

Request a free trial

CorePharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer and manufacturer of solid dose generic pharmaceuticals, including prescription and over-the-counter products.
Pharmaceuticals
Middlesex, NJ
000000000 -

0000 0

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
000000000000000
Petach Tikva, Israel
00000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CorePharma Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

CorePharma Patents

CorePharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090169619-A1 Carbamazepine extended release dosage form Abandoned 25-Feb-2005 000000000 0

CorePharma Executive Team (13)

Name Title Board Seat Contact Info
Arpit Patel Chief Executive Officer & Board Member
Vithal Dhaduk MD Co-Founder, President & Chairman
You’re viewing 2 of 13 executive team members. Get the full list »

CorePharma Board Members (4)

Name Representing Role Since
00000 00000 CorePharma Chief Executive Officer & Board Member 000 0000
000000 000000 00 CorePharma Co-Founder, President & Chairman 000 0000
You’re viewing 2 of 4 board members. Get the full list »

CorePharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CorePharma‘s full profile, request access.

Request a free trial

CorePharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 00 16-Mar-2009 0000000000 Pharmaceuticals 000000000
To view CorePharma’s complete investments history, request access »